BioSpace News Archive

Synthego, a leading provider of genome engineering solutions, announced the launch of its IND-enabling gRNAs, a transformative product offering that revolutionizes the CRISPR-based cell and gene therapy preclinical pipeline.

Affimed N.V., a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced that it has received approval from the Listing Qualifications Department of the Nasdaq Stock Market to transfer the listing of its shares from the Nasdaq Global Market to the Nasdaq Capital Market.

BiomX Inc. announced the completion of patient dosing in Part 2 of the Phase 1b/2a trial evaluating the Company’s novel phage cocktail, BX004, for the treatment of chronic pulmonary infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis.

Immunic, Inc., a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, announced participation in the following scientific conferences in October:

Eurofins CDMO Alphora Inc. is pleased to announce the launch of its Biologics initiative, as part of its vision to diversify and grow within the contract development and manufacturing industry in North America.

Karuna Therapeutics, Inc. announced it will be presenting new secondary efficacy, safety and tolerability, and pooled cognition data from its EMERGENT clinical program evaluating KarXT in schizophrenia.

Eli Lilly and Company announced changes to its executive leadership team.

Vapotherm, Inc. announced the online publication of “Validation of Human Upper Computational Fluid Dynamics Model for Turbulent Mixing” in the Journal of Fluid Dynamics.

Eagle Pharmaceuticals, Inc. announced that its poster, to be presented at the International Society for Anaesthetic Pharmacology 32nd Annual Meeting, has been awarded first prize.

Eton Pharmaceuticals announced it has entered into an agreement to acquire an abbreviated new drug application for Nitisinone Capsules via Oakrum Pharma, LLC’s Chapter 11 bankruptcy proceeding.